Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zur Rose Group AG (ROSE.SW)

Swiss - Swiss Delayed Price. Currency in CHF
28.22-0.10 (-0.35%)
At close: 05:30PM CET
Advertisement

Zur Rose Group AG

Walzmühlestrasse 60
Frauenfeld 8500
Switzerland
41 52 724 00 20
https://www.zurrosegroup.com

Sector(s)Healthcare
IndustryPharmaceutical Retailers
Full Time Employees2,131

Key Executives

NameTitlePayExercisedYear Born
Mr. Walter OberhansliFounder & Chairman1.06MN/A1958
Mr. Walter HessCEO & Member of Exec. BoardN/AN/A1965
Mr. Marcel ZiwicaCFO & Member of Exec. BoardN/AN/A1975
Mr. Bernd GschaiderCOO & Member of Exec. BoardN/AN/A1966
Mr. David MasoHead of Europe & Member of Exec. BoardN/AN/A1971
Mr. Emanuel LoriniHead of Switzerland & Member of the Exec. BoardN/AN/A1977
Mr. Madhu NutakkiCTO & Member of Exec. BoardN/AN/A1971
Christoph HerrmannHead of Investor RelationsN/AN/AN/A
Lisa LuthiHead of Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

Zur Rose Group AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers consumer health, beauty, and personal care products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. The company was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

Corporate Governance

Zur Rose Group AG’s ISS Governance QualityScore as of December 1, 2022 is 5. The pillar scores are Audit: 8; Board: 7; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement